Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 48 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
DR. STALS from As, company number BE0466507939, closed financial year 2026 with a result of € 188,201 after tax. For that financial year DR. STALS recorded a gross margin of € 343,990 and equity of € 1.2 million. Compared with financial year 2025, the result moved from € 197,593 to € 188,201. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.
€ 1.2 million
▲ 19% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 188,201
▼ 5% vs 2025
Profit after tax over the fiscal year.
€ 245,979
▼ 59% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
0 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 42,140
▼ 36% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 22,981
▲ 174% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 5,239
▼ 42% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 296,623 | € 309,453 | € 332,316 | € 343,990 | ▲ 4% |
| Profit after taxes | € 187,236 | € 182,160 | € 197,593 | € 188,201 | ▼ 5% |
| Equity | € 711,148 | € 844,137 | € 964,493 | € 1,151,861 | ▲ 19% |
| Total debts | € 428,761 | € 453,597 | € 516,507 | € 544,162 | ▲ 5% |
| Cash | € 971,997 | € 331,636 | € 602,933 | € 245,979 | ▼ 59% |
| Land & buildings | € 35,886 | € 45,278 | € 47,884 | € 86,782 | ▲ 81% |
| Retained profit | € 692,548 | € 825,537 | € 945,893 | € 1,133,261 | ▲ 20% |
| Dividend | € 178,866 | € 49,171 | € 77,238 | € 833 | ▼ 99% |
| Balance sheet total | € 1,139,910 | € 1,297,734 | € 1,481,000 | € 1,696,023 | ▲ 15% |
Key figures of DR. STALS, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to DR. STALS?
What happened at DR. STALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 188,201 (▼ 5% vs 2025). Source: NBB ↗
- Theo Stals became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in As. KBO
In short
From € 187,236 profit in 2023 to € 188,201 profit in 2026.
Paid € 341,220 in corporate taxes since 2023.
Best year ever: 2025, with € 197,593 profit.
Paid out € 306,108 in dividends to the owners in total.
Management
Behind DR. STALS is Theo Stals.
Directors
According to the 2026 annual accounts
Theo Stals
Director
since 1999
Establishments
Establishment units
Physical locations of this company
Stationsstraat 3
3665 As
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0466.507.939
- VAT number
- BE 0466.507.939
- Registered office
- Stationsstraat 3, 3665 As
- Names & denominations
- DR. STALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 July 1999
- Peppol
- Active · Active since 5 Oct 2025
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria